XML 167 R55.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 19, 2018
Reclassified from line of credit to Notes payable     $ 123,409    
Financing lease right-of-use asset     164,859    
Payable to actuarial expert       $ 408,665  
VAT net receivable and payable balance     534,263 187,512  
Long-term liability     377,264 408,665  
Allowance for doubtful accounts     22,799,219 19,686,091  
Cash on hand     15,067 48,590  
Foreign accounts     293,040 1,047,738  
Sales to Medihelm       367,000  
Other Income       928  
Depreciation expense     387,036 353,043  
Impairment loss     291,980 0  
Other current liabilities $ 3,751,190   3,350,173 3,474,096  
Amortization expense 208,833 $ 189,855 793,836 239,841  
Goodwill $ 49,697   49,697 49,697 $ 49,697
Intangibles Assets [Member]          
Impairment loss     291,980 0  
Customer advances payment          
Other current liabilities     363,708 451,575  
Pancreta Bank [Member]          
Equity method investment aggregate cost     7,665 $ 8,479  
ICC International Cannabis Corp [Member]          
Equity method investment aggregate cost     $ 0    
Equity method investment shares acquired, shares     3,000,000 3,000,000  
Closing price     $ 0 $ 0  
National Bank of Greece [Member]          
Equity method investment aggregate cost     $ 12,766 $ 11,596  
Equity method investment shares acquired, shares     16,666 16,666  
Closing price     $ 0.79 $ 0.70  
Medihelm S.A. [Member]          
Other Income     $ 367,000    
Greece [Member]          
Income tax rate       22.00%  
United Kingdom Of England [Member]          
Income tax rate       25.00%